第一单位：
Department of Women's Cancer, Institute for Women's Health, University College London, London, UK.
作者：
Martin,Widschwendter [1]
;
Allison,Jones [1]
;
Iona,Evans [1]
;
Daniel,Reisel [1]
;
Joakim,Dillner [2]
;
Karin,Sundström [2]
;
Ewout W,Steyerberg [3]
;
Yvonne,Vergouwe [4]
;
Odette,Wegwarth [5]
;
Felix G,Rebitschek [6]
;
Uwe,Siebert [7]
;
Gaby,Sroczynski [8]
;
Inez D,de Beaufort [9]
;
Ineke,Bolt [9]
;
David,Cibula [10]
;
Michal,Zikan [10]
;
Line,Bjørge [11]
;
Nicoletta,Colombo [12]
;
Nadia,Harbeck [13]
;
Frank,Dudbridge [14]
;
Anne-Marie,Tasse [15]
;
Bartha M,Knoppers [16]
;
Yann,Joly [16]
;
Andrew E,Teschendorff [1]
;
Nora,Pashayan [17]
;
FORECEE (4C) Consortium
作者单位：
Department of Women's Cancer, Institute for Women's Health, University College London, London, UK.
[1]
Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.;Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden.
[2]
Center for Medical Decision Sciences, Department of Public Health, Erasmus MC, Rotterdam, Netherlands.;Department of Biomedical Data Sciences, LUMC, Leiden, Netherlands.
[3]
Center for Medical Decision Sciences, Department of Public Health, Erasmus MC, Rotterdam, Netherlands.
[4]
Max Planck Institute for Human Development, Harding Center for Risk Literacy, Berlin, Germany.;Max Planck Institute for Human Development, Center for Adaptive Rationality, Berlin, Germany.
[5]
Max Planck Institute for Human Development, Harding Center for Risk Literacy, Berlin, Germany.
[6]
Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research, and HTA, UMIT-University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria.;Harvard T. C. Chan School of Public Health, Center for Health Decision Science, Department of Health Policy and Management, Boston, MA, USA.;Oncotyrol: Center for Personalized Medicine, Innsbruck, Austria.
[7]
Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research, and HTA, UMIT-University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria.
[8]
Department of Medical Ethics and Philosophy of Medicine, Erasmus Medical Center, Rotterdam, Netherlands.
[9]
Department of Obstetrics and Gynaecology, First Medical Faculty of the Charles University and General Faculty Hospital, Prague, Czech Republic.
[10]
Department of Obstetrics and Gynecology, Haukeland University Hospital, and Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway.
[11]
European Institute of Oncology and University Milan-Bicocca, Milan, Italy.
[12]
Breast Center, Department of Gynaecology and Obstetrics, University of Munich (LMU), Munich, Germany.
[13]
Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.;Department of Health Sciences, University of Leicester, Leicester, UK.
[14]
Public Population Project in Genomics and Society, McGill University and Genome Quebec Innovation Centre, Montreal, Canada.
[15]
Centre of Genomics and Policy, McGill University, Montreal, Canada.
[16]
Department of Applied Health Research, Institute of Epidemiology and Healthcare, University College London, UK.
[17]
DOI
10.1038/nrclinonc.2018.30
PMID
29485132
发布时间
2019-05-21
换一批
